Jacobs Levy Equity Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-42,306
| Closed | -$133K | – | 1160 |
|
|
2019
Q4 | $133K | Hold |
42,306
| – | – | ﹤0.01% | 965 |
|
|
2019
Q3 | $190K | Sell |
42,306
-1,466
| -3% | -$6.58K | ﹤0.01% | 853 |
|
|
2019
Q2 | $208K | Buy |
43,772
+12,887
| +42% | +$61.2K | ﹤0.01% | 875 |
|
|
2019
Q1 | $169K | Sell |
30,885
-22,758
| -42% | -$125K | ﹤0.01% | 909 |
|
|
2018
Q4 | $163K | Hold |
53,643
| – | – | ﹤0.01% | 907 |
|
|
2018
Q3 | $225K | Buy |
53,643
+5,593
| +12% | +$23.5K | ﹤0.01% | 914 |
|
|
2018
Q2 | $186K | Sell |
48,050
-10,677
| -18% | -$41.3K | ﹤0.01% | 963 |
|
|
2018
Q1 | $372K | Buy |
58,727
+32,799
| +127% | +$208K | 0.01% | 826 |
|
|
2017
Q4 | $209K | Buy |
25,928
+8,642
| +50% | +$69.7K | ﹤0.01% | 900 |
|
|
2017
Q3 | $198K | Buy |
+17,286
| New | +$198K | ﹤0.01% | 866 |
|
|
2016
Q3 | – | Sell |
-5,389
| Closed | -$229K | – | 1220 |
|
|
2016
Q2 | $229K | Buy |
+5,389
| New | +$229K | ﹤0.01% | 979 |
|